三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

未开盘 07-30 16:08:10

31.900

-1.650

-4.92%

最高34.000	最低30.900	成交量6,463万
今开32.700	昨收33.550	日振幅9.24%
总市值765.92亿	流通市值765.92亿	总股本24.01亿
成交额20.89亿	换手率2.69%	流通股本24.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":31.9,"timestamp":1753862890006,"preClose":33.55,"halted":0,"volume":64626239,"delay":0,"floatShares":2401000000,"shares":2401000000,"eps":0.939944091569197,"marketStatus":"未开盘","change":-1.65,"latestTime":"07-30 16:08:10","open":32.7,"high":34,"low":30.9,"amount":2088923273,"amplitude":0.092399,"askPrice":31.9,"askSize":214000,"bidPrice":31.85,"bidSize":22500,"shortable":3,"etf":0,"ttmEps":0.9262991600596594,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":0,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":33.55,"dividendRate":0.007837,"openAndCloseTimeList":[[1753839000000,1753848000000],[1753851600000,1753862400000]],"volumeRatio":0.953192,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"2555010508","title":"每日卖空追踪 | 三生制药 07月30日卖空量成交241.05万股，卖空比例为3.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555010508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555010508?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:30","pubTimestamp":1753864224,"startTime":"0","endTime":"0","summary":"三生制药北京时间07月30日，跌4.92%，卖空量成交241.05万股%，较上一交易日减少76.6%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730171929a6c97004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730171929a6c97004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530"],"gpt_icon":0},{"id":"2555901137","title":"三生制药07月30日主力净流出5009.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2555901137","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555901137?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:15","pubTimestamp":1753863355,"startTime":"0","endTime":"0","summary":"07月30日, 三生制药股价跌4.92%，报收31.90元，成交金额20.9亿元，换手率2.69%，振幅9.24%，量比0.95。三生制药今日主力资金净流出5009.8万元，上一交易日主力净流入6473.3万元。该股近5个交易日上涨12.43%，主力资金累计净流入1.4亿元；近20日主力资金累计净流入10.9亿元，其中净流入天数为15日。该股主力净额占比0.07%，港股市场排名2505/2674。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730170206a46b4403&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730170206a46b4403&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","BK1161","BK1583"],"gpt_icon":0},{"id":"2555709467","title":"狂砸4643亿！跨国巨头，正疯抢中国创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2555709467","media":"正解局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555709467?lang=zh_cn&edition=full","pubTime":"2025-07-30 12:05","pubTimestamp":1753848333,"startTime":"0","endTime":"0","summary":"葛兰素史克GSK收购恒瑞新药，只是跨国药企竞逐中国创新药的一个缩影。今年上半年，跨国药企狂砸4643亿元，掀起了一轮对中国创新药的“抢购热潮”。跨国药企外部采购管线来自中国企业的比例这表明，中国的创新药，越来越受到跨国药企的认可。麦肯锡2023年发布的相关报告指出，中国创新药的研发成本仅为美国同行的30%甚至20%。中国创新药BD交易总金额","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730121544a6c8f344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730121544a6c8f344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","600276","AZN","LU2488822045.USD","09995","688331","BK1574","BK1161","06978","01276","LU2328871848.SGD","LU1969619763.USD","PFE","GSK","01801","01530","BK1583"],"gpt_icon":0},{"id":"2555096495","title":"交银国际：升三生制药(01530.HK)目标价至33港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555096495","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555096495?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:44","pubTimestamp":1753843449,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06978","159992","01530","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2555096124","title":"招银国际：升三生制药(01530.HK)目标价至37.67港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555096124","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555096124?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:27","pubTimestamp":1753842469,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE000M9KFDE8.USD","LU1894683348.USD","LU0225771236.USD","LU0456855351.SGD","LU0170899867.USD","BK4588","PD","SGXZ57979304.SGD","BK4581","SG9999003800.SGD","IE00B19Z3B42.SGD","BK4534","LU1883839398.USD","IE0002270589.USD","LU0122379950.USD","LU0289739699.SGD","LU1023059063.AUD","LU0306806265.USD","BK4592","LU1169590202.USD","SG9999002224.SGD","LU0234572021.USD","LU1894683264.USD","BK4568","BK1593","SG9999001176.SGD","BK4007","BK1161","LU0306807586.USD","BK1583","LU1057294990.SGD","SG9999002232.USD","LU0985481810.HKD","SG9999013999.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","01530","BK4023","LU0058720904.USD","IE00B19Z3581.USD","LU1066051498.USD","SG9999001176.USD","LU1066053197.SGD","PFE","LU0321505868.SGD","SG9999011175.SGD","LU0225284248.USD","BK4550","LU0868494617.USD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2555052672","title":"三生制药双抗PD-1/PD-L1双抗706获批两项II期临床，用于治疗消化系统肿瘤和非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052672","media":"三生制药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052672?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:23","pubTimestamp":1753795438,"startTime":"0","endTime":"0","summary":"News7月29日，三生制药宣布，收到国家药监局药品审评中心通知，同意公司开展抗PD-1/PD-L1双抗产品SSGJ-706单药及联合标准化疗在晚期消化系统肿瘤患者中开展II期临床试验，以及SSGJ-706单药或联合化疗在晚期非小细胞肺癌患者中开展II期临床试验。消化系统肿瘤和肺癌均属常见的高发性和高死亡率恶性肿瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729215902a6c7fe19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729215902a6c7fe19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530"],"gpt_icon":1},{"id":"2555594160","title":"三生制药(01530)因购股权获行使而发行153.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555594160","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555594160?lang=zh_cn&edition=full","pubTime":"2025-07-29 20:37","pubTimestamp":1753792661,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2025年7月2日至7月29日，因行使根据2015年5月23日通过的公司购股权计划授予的购股权而发行的153.7万股股票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01530","BK1161","BK1593"],"gpt_icon":0},{"id":"2555035386","title":"港股收评：午后回升！恒指小幅下跌0.15%，创新药涨幅抢眼，三胎概念股高开低走","url":"https://stock-news.laohu8.com/highlight/detail?id=2555035386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555035386?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:21","pubTimestamp":1753777290,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02186","MIUmain","01093","601939","603259","688428","KSTmain","03086","HSImain","01801","BABA","01810","08496","TTTN","02359","688235","TCHmain","HHImain","06978","HTCD.SI","TCEHY","06160","MCHmain","09618","MHImain","HSCEI","09969","METmain","01024","HSI","ALBmain","01530","01288","00939","00700","601288","03690","161726","HSTECH","601398","MPNGY","BIDU","JD","399441","01398","YANG","ONC","159992","07226"],"gpt_icon":0},{"id":"2555863059","title":"三生制药07月29日获主力加仓6473.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555863059","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555863059?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:15","pubTimestamp":1753776939,"startTime":"0","endTime":"0","summary":"07月29日, 三生制药股价涨5.17%，报收33.55元，成交金额20.2亿元，换手率2.56%，振幅9.09%，量比0.90。三生制药今日主力资金净流入6473.3万元，上一交易日主力净流入2.8亿元。该股近5个交易日上涨16.15%，主力资金累计净流入3.0亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入12.1亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729165649a46952a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729165649a46952a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530"],"gpt_icon":1},{"id":"2555877890","title":"大行评级｜招银国际：上调三生制药目标价至37.67港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555877890","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555877890?lang=zh_cn&edition=full","pubTime":"2025-07-29 14:42","pubTimestamp":1753771353,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999002232.USD","IE00BLSP4239.USD","III","LU0306807586.USD","LU0170899867.USD","LU1066051498.USD","PFE","SGXZ57979304.SGD","BK4007","LU1894683348.USD","BK4599","BK1161","BK4134","LU0868494617.USD","BK4534","SG9999002224.SGD","BK4568","SG9999013999.USD","IE0002270589.USD","IE00BBT3K403.USD","LU0122379950.USD","LU0289739699.SGD","BK4585","LU0234572021.USD","LU0321505868.SGD","SG9999003800.SGD","LU0225284248.USD","IE00BLSP4452.SGD","BK4581","SG9999011175.SGD","LU0225771236.USD","LU0058720904.USD","LU0985481810.HKD","PD","IE00B19Z3B42.SGD","BK1583","BK4023","BK1593","SG9999001176.USD","LU1169589451.USD","BK4588","01530","IE00B19Z3581.USD","LU0306806265.USD","LU1023059063.AUD","LU1883839398.USD","BK4550","LU0321505439.SGD","IE000M9KFDE8.USD","BK4592"],"gpt_icon":0},{"id":"2555828710","title":"全线大张！三大利好刺激，创新药赛道大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2555828710","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555828710?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:50","pubTimestamp":1753768228,"startTime":"0","endTime":"0","summary":"创新药赛道大爆发。7月29日，A股、港股市场创新药板块再度全线爆发，多只个股大涨超10%。消息面上，创新药赛道大涨主要受业绩超预期、海外大订单与政策三大利好驱动。光大证券指出，考虑到部分创新药公司BD交易持续催化、细分赛道及正处于转型阶段的公司或有积极变化，应当积极关注板块高质量标的、增加板块配置。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291350409724b29a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291350409724b29a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","06127","LU1997245094.SGD","SBHMY","01530","03347","LU2488822045.USD","688221","06821","BK0028","LU0405327148.USD","GSK","BK0196","02359","LU1328615791.USD","159992","02096","603456","LU2328871848.SGD","688321","LU1064130708.USD","01276","BK0060","LU1969619763.USD","BK0183","LU1064131003.USD","LU1997245177.USD","603127","LU1655091616.SGD","LU1997244956.HKD","603367","600276","00853","LU2148510915.USD","BK0012","603229","01093","LU0405327494.USD","603259","BK0239","02186","01177","LU2495084118.USD"],"gpt_icon":0},{"id":"2555308240","title":"瑞银：升三生制药(01530.HK)目标价至41港元 看好SSGJ-707销售表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2555308240","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555308240?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:39","pubTimestamp":1753767544,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1593","BK1583","01530"],"gpt_icon":0},{"id":"2555089805","title":"港股异动 | 三生制药(01530.HK)涨超4%再创新高 与辉瑞授权协议正式生效 1.5亿美元再售707中国内地权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089805","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089805?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:02","pubTimestamp":1753758160,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","SG9999003800.SGD","BK4534","LU1066051498.USD","BK4533","SG9999011175.SGD","LU1894683348.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU1894683264.USD","SG9999002232.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","BK4007","LU0868494617.USD","IE00B19Z3581.USD","LU0306807586.USD","LU1023059063.AUD","SG9999002224.SGD","SG9999001176.USD","LU0456855351.SGD","BK1161","BK4599","LU0289739699.SGD","LU0321505868.SGD","01530","LU0234572021.USD","LU0225771236.USD","LU0321505439.SGD","IE00BLSP4239.USD","LU1057294990.SGD","IE0002270589.USD","SG9999013999.USD","LU0122379950.USD","LU0985481810.HKD","LU1066053197.SGD","PFE","IE00BLSP4452.SGD","BK4581","LU1883839398.USD","BK4585","BK4550","IE000M9KFDE8.USD","BK1583","LU0225284248.USD","LU0058720904.USD","BK4592","LU0170899867.USD","BK4568","LU0306806265.USD"],"gpt_icon":0},{"id":"2554672566","title":"港股异动 | 创新药概念多数走高 行业迎政策红利密集释放期 BD有望加速创新药重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2554672566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554672566?lang=zh_cn&edition=full","pubTime":"2025-07-28 14:52","pubTimestamp":1753685525,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1997244956.HKD","LU1997245094.SGD","LU1064131003.USD","03692","BK0196","LU2148510915.USD","BK1521","LU2328871848.SGD","BK0239","600276","LU1969619763.USD","BK0188","LU2495084118.USD","BK1583","BK1515","LU1655091616.SGD","159992","LU0405327148.USD","LU2488822045.USD","06978","BK0012","BK0183","LU0405327494.USD","BK1593","LU1064130708.USD","02096","BK0028","01801","BK0060","01530","BK1191","BK1161","BK1574","LU1997245177.USD","BK1589","01276","IE00BZ08YT58.USD","01177","LU1328615791.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"1169483721","title":"三生制药年初至今股价累涨近400%！瑞银上调其目标价，看好SSGJ-707销售表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1169483721","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169483721?lang=zh_cn&edition=full","pubTime":"2025-07-28 14:16","pubTimestamp":1753683414,"startTime":"0","endTime":"0","summary":"7月28日，$三生制药(01530)$涨近6%，年初至今股价累涨近400%！$瑞银(UBS)$上调其目标价，看好SSGJ-707销售表现。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药年初至今累涨近400%！瑞银上调其目标价，看好SSGJ-707销售表现","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","01530","BK1583","BK1161"],"gpt_icon":0},{"id":"2554234517","title":"三生制药再涨近6%辉瑞计划快速推进707在全球的III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2554234517","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554234517?lang=zh_cn&edition=full","pubTime":"2025-07-28 14:05","pubTimestamp":1753682700,"startTime":"0","endTime":"0","summary":"三生制药与辉瑞达成全球授权协议，将额外获得1.5亿美元款项，辉瑞计划快速推进707的III期临床试验。瑞银上调三生制药销售预测，预测其收入及净利润将大幅增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072814191294bebbad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072814191294bebbad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","LU1066051498.USD","SG9999001176.SGD","IE00B19Z3581.USD","BK4533","LU0058720904.USD","SG9999003800.SGD","SG9999011175.SGD","IE0002270589.USD","SGXZ57979304.SGD","01530","LU1023059063.AUD","BK4134","BK4007","SG9999002232.USD","LU0289739699.SGD","BK4599","LU1894683264.USD","LU0170899867.USD","BK4592","III","LU0321505868.SGD","PFE","BK4534","IE000M9KFDE8.USD","LU0234572021.USD","LU0868494617.USD","SG9999002224.SGD","LU1057294990.SGD","LU0321505439.SGD","LU0985481810.HKD","IE00BLSP4452.SGD","LU0225771236.USD","LU1883839398.USD","LU0225284248.USD","LU0306806265.USD","LU1066053197.SGD","LU0456855351.SGD","BK4568","SG9999001176.USD","IE00BLSP4239.USD","SG9999013999.USD","BK4585","BK4581","LU0122379950.USD","BK4588","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU0306807586.USD","LU1894683348.USD"],"gpt_icon":0},{"id":"1128950789","title":"异动解读 | 三生制药盘中大涨5.27%，辉瑞加速推进双抗新药全球开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1128950789","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128950789?lang=zh_cn&edition=full","pubTime":"2025-07-28 13:41","pubTimestamp":1753681272,"startTime":"0","endTime":"0","summary":"7月28日，三生制药股价盘中大涨5.27%，引发市场关注。此轮涨势主要受益于公司与辉瑞达成的重磅合作协议正式生效，以及多家券商上调公司目标价。根据协议，三生制药将获得12.5亿美元首付款，以及最高48亿美元的里程碑付款和双位数分级销售分成。此外，辉瑞还将以每股25.2港元认购三生制药约7.85亿港元股份。市场分析认为，辉瑞计划加速推进SSGJ-707在全球的III期临床试验，这将显著提升该药物的开发进程。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01530"],"gpt_icon":0},{"id":"1191720855","title":"异动解读 | 三生制药盘中大涨5.27%，辉瑞加速SSGJ-707全球开发计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1191720855","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191720855?lang=zh_cn&edition=full","pubTime":"2025-07-28 13:40","pubTimestamp":1753681228,"startTime":"0","endTime":"0","summary":"三生制药今日盘中大涨5.27%，引发市场关注。消息面上，三生制药近日公布与辉瑞就PD-1/VEGF双特异性抗体SSGJ-707达成的全球授权协议已于7月24日正式生效。市场分析人士认为，辉瑞计划加速SSGJ-707在全球的III期临床试验，评估其单药及联合疗法的潜力，这将有助于加快该药物的开发进程。SSGJ-707在此前公布的临床数据中展现出良好的疗效，在34例患者中实现64.7%的客观缓解率。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01530"],"gpt_icon":0},{"id":"2554747080","title":"港股异动 | 三生制药(01530)午前涨近3% 近日与辉瑞订立许可协议 后者计划加速SSGJ-707开发进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2554747080","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554747080?lang=zh_cn&edition=full","pubTime":"2025-07-28 11:45","pubTimestamp":1753674327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药午前涨近3%，截至发稿，涨2.46%，报29.15港元，成交额6.39亿港元。消息面上，近日，三生制药公布，公司与辉瑞就PD-1/VEGF双特异性抗体订立的许可协议之所有先决条件已达成，许可协议自7月24日起生效。招银国际指出，辉瑞计划快速推进707在全球的III期临床试验，评估其单药及联用化疗、ADCs等联合疗法的潜力。辉瑞拥有丰富的临床资源和先进的ADC药物储备，如PADCEV、sigvotatug vedotin和PDL1V，这些都将有助于加速707的开发进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 三生制药(01530)午前涨近3% 近日与辉瑞订立许可协议 后者计划加速SSGJ-707开发进程","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002270589.USD","LU1057294990.SGD","LU1894683264.USD","SG9999001176.SGD","SG9999011175.SGD","LU1894683348.USD","LU0170899867.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0289739699.SGD","LU0306806265.USD","LU0122379950.USD","LU0321505868.SGD","SG9999002224.SGD","BK4007","IE00BBT3K403.USD","BK4550","LU1066053197.SGD","SG9999002232.USD","IE000M9KFDE8.USD","01530","SG9999001176.USD","BK4534","LU0868494617.USD","IE00B19Z3581.USD","LU0985481810.HKD","SGXZ57979304.SGD","LU0306807586.USD","BK1161","BK4588","BK4568","LU0058720904.USD","LU0456855351.SGD","BK4533","BK1593","BK4599","IE00BLSP4452.SGD","SG9999013999.USD","BK4592","LU0225771236.USD","BK4585","SG9999003800.SGD","LU1883839398.USD","BK4581","IE00BLSP4239.USD","LU0321505439.SGD","BK1583","LU1066051498.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2554281807","title":"医药生物：2025年2季度医药行业基金持仓结构分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2554281807","media":"天风证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554281807?lang=zh_cn&edition=full","pubTime":"2025-07-28 00:00","pubTimestamp":1753632000,"startTime":"0","endTime":"0","summary":"2025Q2被动医药基金规模为1434亿元，达到历史最高值。从基金份额上看，截至2025Q2，主动医药基金份额为1042亿份，相较于2025Q1环比减少196亿份。因此主动药基规模的提升，仍系股价上升。2025Q2被动医药基金份额为2580亿份，环比减少89亿份。医药基金重仓持股：从医药基金重仓持股比例看：2025Q1主动医药主题基金持仓前三行业分别为创新药（41%）/传统制药（34%）/CDMO（13%）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728132123a4670024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728132123a4670024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","01530","BK1161","688506","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":0.1173},{"period":"1month","weight":0.3597},{"period":"3month","weight":1.6886},{"period":"6month","weight":4.3506},{"period":"1year","weight":4.4132},{"period":"ytd","weight":4.2885}],"compareEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.1382},{"period":"6month","weight":0.2448},{"period":"1year","weight":0.4807},{"period":"ytd","weight":0.2551}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003687},{"month":2,"riseRate":0.5,"avgChangeRate":0.007795},{"month":3,"riseRate":0.8,"avgChangeRate":0.121345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.039029},{"month":8,"riseRate":0.4,"avgChangeRate":-0.006266},{"month":9,"riseRate":0.6,"avgChangeRate":0.02732},{"month":10,"riseRate":0.4,"avgChangeRate":-0.022805},{"month":11,"riseRate":0.7,"avgChangeRate":0.064411},{"month":12,"riseRate":0.5,"avgChangeRate":-0.027207}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}